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A historical review of the development of biokinetic model of lead is presented. Biokinetics is
interpreted narrowly to mean only physiologic processes happening within the body. Proceeding
chronologically, for each epoch, the measurements of lead in the body are presented along with
mathematical models in an attempt to trace the convergence of observations from two disparate
fields-occupational medicine and radiologic health-into some unified models. Kehoe's early
balance studies and the use of radioactive lead tracers are presented. The 1960s saw the joint
application of radioactive lead techniques and simple compartmental kinetic models used to
establish the exchange rates and residence times of lead in body pools. The applications of stable
isotopes to questions of the magnitudes of respired and ingested inputs required the
development of a simple three-pool model. During the 1980s more elaborate models were
developed. One of their key goals was the establishment of the dose-response relationship
between exposure to lead and biologic precursors of adverse health effects. Environ Health
Perspect 106(Suppl 6):1461-1465 (1998). http://ehpnetl.niehs.nih.gov/docs/1998/Suppl-6/
1461-1465rabinowitz/abstract.html
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Consideration of lead biokinetics from a
historical perspective promises to provide
some useful insights. The evolution of our
thinking on this topic reveals which con-
cerns or problems are transient, dealt with
once years ago and no longer requiring fur-
ther validation, and which issues seem to be
recurring, and the forms these recurring
topics take today.
For this presentation the term biokinetics
is interpreted rather narrowly to mean only
physiologic processes happening within the
body. It is concerned with how lead is dis-
tributed within our body rather than the
many processes in the environment that
bring the lead to the mouth. These bio-
kinetic models are conceptual, numerical
descriptions that could explain observa-
tions or predict hypothetical situations. So
the emphasis in this article is our changing
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understanding of how lead is distributed
within the body, how long it resides there,
and how it is excreted. Less stress is placed
on means of exposure or uptake of envi-
ronmental lead. Proceeding chronolog-
ically, for each epoch the measurements of
lead in the body will be presented along
with mathematical models in an attempt
to trace the convergence of observations
from two disparate fields-occupational
medicine and radiologic health-into
some unified models.
Early Observations
The earliest clinic observations of lead
poisoning noted its peculiar time course.
The Devonshire colic, documented by Sir
George Baker in 1768, serves as an exam-
ple (1). It was caused by the use of lead in
apple cider presses and vats. Sometimes
lead metal was added to the cider to pre-
vent spoilage. The abrupt onset of abdomi-
nal symptoms was some time after the
patient started to drink the tainted cider,
longer than simple food poisoning. The
palsy came even later. Even in cases of fatal
outcome, the symptoms did not appear
with the onset of exposure. The notion was
that the delay in onset of symptoms was
caused by the accumulation of lead in the
body until it reached sufficient levels.
Similar experience with industrial lead
poisoning, for example, noted by Charles
Dickens in 1861 (2), reinforced this
notion that illness, should it come, would
not come immediately, but only after
sufficient time for the lead to accumulate.
Moving forward to the 1930s in
Cincinnati, Ohio, Kehoe et al. (3) reported
studies of the absorption and excretion of
lead in normal adults and in those with
lead poisoning. These included dosing
human volunteers and measuring their
intakes, outputs, and blood lead levels.
Kehoe et al. reported that small, natural
amounts of lead are present in human tis-
sues. They used a spectrographic method
but did not appreciate until later the role
of laboratory contamination of samples.
They reported mean blood lead levels of
nonexposed adults prior to 1938 to be 58
pg/dl, with 75% being between 20 and 70
pg/dl. Later they reduced this value by
about one-half. Kehoe et al. (4) stated that
lead intake and excretion were in near bal-
ance, and with increased exposure and
absorption came increased excretion, but
the balance was not neutral. There was
some accumulation of lead; about 8% of
daily intake in normal adults was retained.
Unfortunately, Kehoe's conclusions
were based on small differences in lead
content among samples, so small errors
produced by unappreciated contamination
caused difficulties in measuring lead levels.
This was especially true in the normal,
nonpoisoned subjects, for example, in
comparing the differences between diet,
feces, and urinary output and relating the
net differences to changes in blood lead
levels. Of course, in situations of gross lead
intake-more than 1 mg/day-these errors
became less important. Furthermore,
Kehoe did not seem to appreciate, or did
any of his generation of researchers, that,
even after he made more adequate blank
corrections in 1938 and later and obtained
what he thought were normal values for
blood lead of less than 30, the values he
considered normal were actually those of
lead-contaminated urban Americans.
Natural lead levels were many times lower.
By 1938 some authors concluded that
lead levels in blood were a more reliable
index of lead absorption than lead excreted
in urine according to Traeger and Schmitt
(5) in Germany, who relied on colorimetry.
Teisinger (6) and Bass (7) using electro-
chemical methods, reached the same conclu-
sion. Earlier, using emission spectroscopy,
Shipley et al. (8) at Johns Hopkins found
that blood lead concentrations were useful
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for the diagnosis of lead poisoning.
Similarly, Willoughby and Wilkins reported
that blood lead concentrations are more
stable than those in urine
Similar studies were carried out in the
1950s by Imamura (10), who tried to
duplicate Kehoe's approach in a Japanese
setting. Imamura illustrated the presence of
lead in the body. He found that lead accu-
mulated in the bodies of control cases and
that lead excretion was always less than
lead exposure. Among men who were given
first 3 mg and then 6 mg lead daily, cumu-
lative lead excretion never accounted for
the total dose, and the balance accumu-
lated daily. About 15% of the dose
remained in the body. The mean blood
lead among controls was 32 pg/dl, and it
reached 80 pg/dl for the lead takers. At
most only 10 mg of the absorbed lead
would remain in the blood, the other
50 mg was thought to be elsewhere in the
body, only to leave slowly over a period of
many months.
Application of
Radioactive Tracers
Meanwhile, and separately, during the
1940s tremendous advances were being
made with the use of radioactive isotopes in
physiology and medicine. It was recognized
that many physiologic and biochemical
processes, hitherto quite unmeasurable,
could be quantified with tracers (11). For
example, Shemin and Rittenberg (12) deter-
mined the biologic half-life of human red
blood cells using a radioactive glycine label.
The mathematical analysis of these
tracer experiments was also being formal-
ized. Chemical kinetics were applied to
compartments or pools of physiologic
interest. By measuring the rates of dis-
appearance of radioactive tracers, it was
possible to identify pools of distribution
of the compound within the body and
estimate both the exchange rates among
the pools and the pools' turnover time.
These equations took the form of coupled
differential equations that had solutions
in the form of sums of terms with expo-
nential decay factors. Simple one and
two-pool models were written so that
experimental data could be converted to
rates (13).
Stable isotope tracers as well as
radioisotopes were under consideration,
using Geiger counters and Nier-type mass
spectrometers (14). There was little delay
before radioactive tracer methodology and
concepts of compartmental analysis were
applied to lead measurements. However,
the application of stable isotopes would
take another quarter-century. By 1954 the
metabolism of lead in dogs was being stud-
ied with 210Pb (20-year half-life)(15). Also,
radioactive 203Pb (52-hour half-life) was
used to study tissue uptake of lead in rats
(16). Generally these studies examined the
uptake of the radioactive lead by different
organs and how that uptake and release
could be modified by citrate, which was
used to treat lead poisoning at the time
(17). These and other early applications of
radioactive lead are reviewed by Wolf and
Fischer (18). By 1957 the use and sophisti-
cation of these mathematical models had
reached the level of complication necessary
to explain the simplest issues of lead
biokinetics, a three-pool model (19).
The 1960s saw the joint application of
radioactive lead techniques and simple
compartmental kinetic models to establish
the exchange rates and residence times of
lead in body pools. Catellino and Aloj
(20) determined the elimination constants
of 210Pb from various rat tissues. They
killed 10 groups of five rats from 1 to 336
hr after intravenous administration of a
1 00-jg dose of labeled lead acetate. They
identified slow and fast pools, with rapid
elimination from the blood and slow elim-
ination from the bones. They recognized
that lead was bound reversibly to tissues.
Another early application of radioactive
lead was to examine whether human teeth
could serve as good indicators of skeletal
lead stores. This was of interest because
radioactive lead is an 0-emitter and large
internal doses were of concern from the
viewpoint of radiologic health. Researchers
found that the tooth-to-tooth variability of
these extracted adult teeth was 25% within
the same individual, which was viewed as
troublesome. Correlations between teeth
and a postmortem iliac crest specimen were
significant. The authors concluded that
teeth were as adequate as small bone
samples in estimating skeletal burdens of
a-emitting bone-seeking elements. There-
fore, as early as 1963, teeth were recognized
as biomarkers for lead stores (21).
A significant mathematical advance
was the recognition that lead and other
trace elements occur in environmental
samples, including food and water in
concentrations that approach a log-normal
distribution. The daily amounts of intake
and output from the body were then
viewed as randomly distributed. The
mathematical distribution for the amount
of lead stored in the body as a whole was
found to be log-normal (22).
Also in the 1960s, Holtzman (23) at
the Argonne National Laboratory consid-
ered the dynamics of lead within the
body. 2`0Pb was a potential radiologic
concern on its own, but it also was an
indicator of other radon daughter prod-
ucts as well. Special attention was given to
the uptake of lead by bone and its
residence time there because the skeleton
was a key target organ in terms of radio-
logic safety. The long half-life of 210Pb
(21 years) lends itself to the study of the
slow process, which may take decades.
Holtzman was among the pioneers who
applied numeric models of compart-
mental analysis to predict lead levels over
time in different parts of the human body.
Among his observations was a bone
retention half-life estimate of 17 years,
which has held up well as more recent
accumulations of estimates have become
available. One recent case report involves
being able to measure 210Pb both in the
urine and retained, by y-emissions from
the skull, over a 10-year follow up. It has
yielded long-term half-lives of 16± 1 and
18 ± 5 years (24).
Barltrop and Smith's work with
radioactive lead demonstrated the uptake
of lead by red blood cells (25). They also
recognized the firm but reversible nature
of lead's binding. During the late 1960s
and the 1 970s, a series of experiments
with radioactive lead were carried out
including those by Hursh (26), who
examined the time course of 210Pb in dogs
and presented a model with four exponen-
tial terms. He clearly showed blood and
urine elimination dynamics. His other
studies on men who inhaled 212Pb(10-hr
half-life) yielded invaluable estimates of
absorption and clearance, processes that
occur within a day or two (27). He also
fed men 212Pb to calculate gut absorption
rates (28). Although these were very useful
studies, because of the short half-life of
212Pb, processes longer than a few days
cannot be examined; such processes
include blood pool turnover, biliary
excretion and other sources of endogenous
fecal excretion, or hair or nail uptake.
Chamberlain (29) later summarized these
efforts, using them to estimate the impact
of airborne lead.
Stable Isotope Tracers
At about this time, from 1970 to 1975, I
employed stable isotope tracer methods at
University of California Los Angeles (30).
My teachers George Wetherill and Joel
Kopple enabled me to address the question
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of how much lead was entering people by
respiration compared to ingestion. In Los
Angeles in the early 1970s, this was a
matter of concern. We fed the volunteers a
low-lead diet supplemented with tracer
204Pb, which is nonradioactive. As such,
204Pb has distinct advantages over 212Pb,
which has such a short half-life that phe-
nomena taking more than a few days
cannot be investigated. Similarly, it is more
useful than 210Pb, which has such a long
radioactive half-life (21 years) and a
decades-long biologic half-life that to get
measurable amounts of disintegration, the
lifetime exposure to radiation would be
unacceptably high.
We observed the rapid appearance of
the tracer in the feces and urine and its
gradual accumulation in the blood (31).
After some months, the extent of labeling
of the blood did not increase but reached a
near steady state, reflecting the mixture of
the blood daily inputs: from the labeled
diet and the unlabeled air but also some
amount from the unlabeled skeletal stores.
Consequently, a large part of our efforts-
and this included modeling-was required
to estimate this skeletal output and
account for it as we estimated the relative
magnitudes of the two external inputs, air
and food. A simple linear model of three
well-mixed compartments was sufficient
for our purpose.
Skeletal lead output was determined by
discontinuing the labeled diet and watching
the very slow, long-term disappearance of
the tracer in the blood and urine, which is
tracer that had been stored in the skeleton
during the feeding portion of the study. We
also had to know the relative amounts of
labeled and unlabeled lead in the skeleton;
and although modeling was useful, several
iliac biopsies provided an additional esti-
mate of the turnover and pool size of the
skeletal pool. So, in the process of trying to
estimate the size of the daily respired lead
intake, we were forced to estimate the
impact of the skeletal pool and to devise a
simple three-pool model (32).
We had no doubt that an actual body is
composed of many more pools, since we
saw different tracer uptake rates in differ-
ent types of samples: feces, blood, bile,
pancreatic secretions, saliva, sweat, facial
hair, nails, and bone. Each sample type had
a different extent of labeling, so each must
come from a different pool, since pools
are, by definition, well mixed (33).
However, we considered three pools to be
sufficient for our study. Additional ancil-
lary information was gathered about gut
absorption factors, the blood pool volume
of distribution and its turnover, endoge-
nous fecal excretion, and the urinary
clearance rates (34).
The gradual rise and slow decline we
saw in tracer lead was remarkably similar
to the changes seen in blood lead levels
in the occupationally exposed population,
which was also being well documented
in the early 1970s. Both total lead and
tracer lead moved with response times of
almost a month plus a smaller, longer
term component (35).
This similarity encouraged modelers. By
1977 data were available for both the rapid
pools and the slower pools, as different
radioactive isotopes with very different half-
lives had been used. Also, some radioactive
lead is the daughter of 214Bi, and bismuth
distributions are different from lead distrib-
utions. For this reason Bernard (36) created
a more complete model.
This sluggish response of blood to
changes in exposure is caused by the long
residence time of lead in blood, about a
month (37). The longer term accumula-
tion of lead in the skeleton is seen as a
future source of blood lead. This release of
stored lead is the rate-limiting factor in its
clearance of lead from the blood. Even if
the kidneys were functioning with youthful
efficiency, filtering lead from the blood
plasma, the slow release of lead from bone
would still be responsible for blood lead
being elevated years after the accumulation
of exposure was discontinued. This has
been noted also in clinical (38) and indus-
trial settings (39), as well as with stable
isotope tracers.
Recent Efforts
During the 1980s more elaborate models
of whole body lead metabolism were
presented. Kneip et al. (40) presented a
somewhat more complex model with six
compartments, based on radioactive lead
studies of infant and juvenile baboons.
This approach had the advantage of
allowing for age-specific changes in lead
metabolism, as it was thought to be more
appropriate to children than a model based
on adult men.
One of the key accomplishments of the
1980s supported by the U.S. Environmental
Protection Agency (U.S. EPA) was the estab-
lishment of the dose-response relationships
between time-varying patterns of exposure to
lead and biologic precursors of adverse health
effects (41). To this end Marcus (42)
created a series of models for the long-term,
bone-related activity, considering the bone as
several compartments, as well as considering
the blood pool as composed of three quicker
pools in blood. These biokinetic models are
the precursors of the biokinetic uptake
models we are considering today. A six-pool
model introduced by Bert et al. (43) in
1989, does a better job than the Bernard
model of predicating events with a time scale
of months by virtue of its inclusion of pools
of intermediary half-lives.
The 1980s also saw additional extension
in scope of experimental studies of lead
metabolism. Heard and Chamberlain (44)
performed a series of experiments with
203Pb (48-hr half-life). After intravenous
injections, gamma counting the y-ray emis-
sion from the feet was used to estimate
skeletal uptake. Urinary output and blood
samples allowed calculations of the fate of
dose and clearance rates. Skeletal uptake,
whole blood and plasma, and urinary clear-
ance rates of lead were calculated and com-
pared to other alkaline earth elements,
calcium and strontium. In a separate series
of studies, adults were fed 203Pb in solution
and incorporated into lamb organ meats
and vegetables (45). Coincident ingestion of
tea, coffee, beer, calcium, and phosphate
were also measured. Absorption rates varied
from 3 to 19% and up to 50% while sub-
jects were fasting. Other studies sought bet-
ter understandings of tracer methodology
and factors modulating oral inputs. Com-
pared to the earlier studies with 212Pb, the
longer half-life of 203Pb allowed for the
examination of slower processes. Keller and
Doherty (46) studied lead kinetics in devel-
oping and adult mice using 210Pb. They
observed that a simple, three-compartment
model did not adequately account for brain
lead levels.
In addition to whole body kinetics, the
many details of cellular lead metabolism
received closer attention. For example,
Pounds and Mittlestaedt (47) examined
the cellular metabolism of lead in isolated
rat hepatocytes. Fowler et al. (48) used
203Pb to study lead interactions with the
kidney cortex components such as the
brush-border membrane. Rosen (49)
examined lead and calcium and the osteo-
cyte. Each of these studies is of interest in
terms of the storage and release of lead,
but each one also tells us much about the
kinetics of the several specific targets of
lead toxicity, such as the kidney and
subcellular sites.
It is too early to write a history of
advances in lead biokinetics in the 1990s,
but some accomplishments and trends are
quite apparent. Models are not getting any
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simpler. At the same time that there has
been this elaboration with more and more
pools, there have also been efforts to recon-
cile these mathematical models with epi-
demiologic data. In a recent review, Mushak
(50) noted that recent advances in the area
of toxicokinetics of lead are explaining the
role of past lead exposure in the values
obtained from longitudinal lead studies and
intervention trials, and in elucidating the
impact of approaching menopause on
women who grew up in the 1940s to 1970s
when environmental lead levels were
generally much higher than they are today.
Three recent modeling efforts are esp-
ecially worth mentioning here. O'Flaherty
(51) has published a series of physiologically
based models. This model has been cali-
brated for children, and has the virtue of
containing age-dependent terms for bone
growth and bone mass as well as age-
dependent ingestion rates and dietary
changes. This allows testing of blood and
bone lead levels to be more labile during
early childhood, tracking environmental
levels fairly closely. A similar model was
developed for adults (52).
Legett has presented an age-specific
kinetic model of lead metabolism (53) that
was developed within a physiologically based
framework designed to address calciumlike
bone-seeking elements. Although originally
conceived to address environmental alkaline
earth radionuclides, which would include
lead, it is a credible and versatile method for
examining the response of humans to
changes in their lead exposure. A rather com-
plete, elaborate, multiple-pool model is
offered with generally linear, first-order
transport among the pools. The actual para-
meters used for each of the 39 pathways
were derived, as much as possible, from
available experimental tracer data from the
literature. These parameters are allowed to
change with age. Nonlinear plasma-red cell
relationships are introduced. The model is
generally consistent with data from a variety
of experimental and natural conditions.
The most recent example of such a
multipool model is a series of integrated
environmental uptake biokinetic models
generated by the U.S. EPA. An early exam-
ple is LEAD, version 0.5, produced by the
Environmental Criteria (Research Triangle
Park, NC 27709) and Assessment Office,
designed in 1991 for use on IBM PC-
compatible microcomputers running DOS
as a stand-alone software program that uses
the concentrations of lead in various
environmental media (air, water, soil, etc.)
to predict the blood lead distributions in
children of various ages. It consists of
interconnected pools or body compart-
ments. The intended use is to assess the con-
sequences of alternative lead exposure
scenarios in terms of the percentage of the
children whose blood lead would exceed any
given standard. These models, with their
many pools and transfer rates, can be varied
to fit existing blood lead data without regard
to the extent of lead in these many interme-
diate pools. Only the blood lead fit is used
as an index of goodness of fit, so there are
ample degrees of freedom.
An additional topic that has received
increasing attention is the interaction
between lead and neurons (54). In the
search for the impact of lead at each target
organ, it seems the study of neurons offers
the chance to examine lead's effects at the
lowest effect level. There is a fast-growing
body of literature in this area and only one
recent example will serve as an introduc-
tion. The developing brains of tadpoles
were exposed to lead in nanomolar con-
centrations. Lead reduced the area and
branch tip number of retinal ganglial cell
axon arborization. Their stunting by lead
was reversed by administering dimethyl-
L-succinic acid (DMSA) chelator. Clearly,
we need to learn more about lead interac-
tions with target tissues in terms of the
kinetics of thresholds and reversibility or
permanence of lead's toxic effects.
Conclusion
Biokinetic models that have been con-
structed usefully describe the general charac-
teristics of lead toxicity, observations of its
clinical course, and laboratory findings. The
clinical picture of chronic plumbism is
marked by latency of onset of symptoms
and by frequent remissions. Responding to
changes in exposure, blood lead levels rise
faster than they fall. Another peculiar fea-
ture of lead toxicity is the relatively large
amount of lead that can be held innocu-
ously in the skeleton, while much smaller
quantities of lead are toxic to neurons. Also,
biokinetic models provide a conceptual
framework for interpreting this variety of
clinical and laboratory findings. Of course,
risk assessment of radioactive lead would be
impossible with biokinetic models.
Because opportunities for lead exposure
can come from a variety of sources, expo-
sure assessment and risk characterization
require the use of biokinetic models. This
need extends to children, the occupation-
ally exposed, and elderly adults, whether
they be exposed to lead via soil, dust,
water, food, or air. At this workshop we
heard how these models are being used as a
guide to help risk assessors and managers
to identify populations at risk, to predict
the effectiveness of intervention, to set
clean-up standards, and to determine if a
house or neighborhood requires remedia-
tion. A better understanding of the extent
to which a particular biokinetic model
should be used for a certain situation is one
of this workshop's main purposes, but such
questions are beyond the narrow scope of
this historical presentation.
A major limitation of current models
is the limited data on which they are
based. It is striking how many different
attempts at modeling used human data
from 1970 to 1975 and how very little
new data there is, on adults, children, or
chimpanzees. A noteworthy study under-
way in Australia is watching blood lead
isotopic composition change during preg-
nancy in women who immigrated with
unusual amounts of lead stored in their
bones (55). Another recent study [Smith
et al. (56)] compares lead ratios from
bone biopsies with those from blood.
These studies directly address the issue of
mobilizing bone lead stores. But these
ongoing efforts aside, I believe that the
field has developed as far as it can without
more new data on lead kinetics. Such
tracer studies on volunteers are safe, and
automated mass spectrometers can now
run a rack of samples in one day.
Twenty-five years ago, a study reported
lead data for five adult males. For bio-
kinetic studies to be more useful, we
should have available much more human
data. Also, we could consider how chela-
tors modify these lead pathways and pools.
Modeling, particularly including the target
sites, also has something to contribute to
the questions of thresholds or reversibility
or permanence of lead's effects.
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